|
STRAP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04109999999424E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.34899999995708E-06 |
| Normal-vs-Stage2 |
4.531700E-02 |
| Normal-vs-Stage3 |
4.734400E-01 |
| Normal-vs-Stage4 |
8.309400E-01 |
| Stage1-vs-Stage2 |
7.660400E-01 |
| Stage1-vs-Stage3 |
8.730300E-02 |
| Stage1-vs-Stage4 |
1.666850E-01 |
| Stage2-vs-Stage3 |
3.136200E-01 |
| Stage2-vs-Stage4 |
2.898000E-01 |
| Stage3-vs-Stage4 |
8.215000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.86571999999385E-05 |
| Normal-vs-AfricanAmerican |
6.244200E-02 |
| Normal-vs-Asian |
6.297600E-01 |
| Caucasian-vs-AfricanAmerican |
2.697400E-01 |
| Caucasian-vs-Asian |
7.276600E-01 |
| AfricanAmerican-vs-Asian |
9.746200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.95369999961481E-07 |
| Normal-vs-Female |
3.998200E-01 |
| Male-vs-Female |
7.342100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.367610E-02 |
| Normal-vs-Extreme_Weight |
7.31920000052177E-07 |
| Normal-vs-Obese |
2.708400E-02 |
| Normal-vs-Extreme_Obese |
2.408300E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.078200E-01 |
| Normal_Weight-vs-Obese |
6.692800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.192800E-01 |
| Extreme_Weight-vs-Obese |
6.111800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.550600E-01 |
| Obese-vs-Extreme_Obese |
2.159800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.167600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.796500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.88860000000157E-05 |
| Normal-vs-Age(81-100Yrs) |
5.672400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.817800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.861960E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.144300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.947800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.271800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.305200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.59536999999599E-05 |
| Normal-VS-Type2 PRCC |
3.119800E-03 |
| Normal-VS-KIRP CIMP |
1.969180E-01 |
| Normal-VS-Unclassified PRCC |
3.113800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.124600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.338100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.858990E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.066160E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.426800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.985600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.171100E-04 |
| Normal-vs-N1 |
4.470600E-01 |
| Normal-vs-N2 |
7.676600E-01 |
| N0-vs-N1 |
1.380430E-02 |
| N0-vs-N2 |
1.340790E-01 |
| N1-vs-N2 |
9.732200E-01 |
|
|
